Benufutamab (GEN1029) is a DR5-Specific Agonistic Antibody for Solid Tumor Research
Death receptor 5 (DR5), also known as TRAIL receptor 2 (TRAILR2) and TNFR superfamily member 10B (TNFRSF10B), is a cell surface receptor of the TNF-receptor superfamily that binds TRAIL and…